Johnson & Johnson (JNJ) Shares Up 53% in Past Year

AI Summary

Johnson & Johnson (JNJ) shares have gained 53% over the past year and are up 15% year-to-date. Leerink Partners upgraded JNJ's shares on May 13th, raising the price target from $252 to $265. The firm believes that JNJ's new drugs will contribute to revenue growth and share price performance. Additionally, JNJ has seen a 7.7% increase in share price over the past month amid market liquidity issues.